CORRECTION article

Front. Microbiol., 11 July 2025

Sec. Antimicrobials, Resistance and Chemotherapy

Volume 16 - 2025 | https://doi.org/10.3389/fmicb.2025.1638611

Correction: Mesalazine: a novel therapeutic agent for periodontitis via regulation of periodontal microbiota and inhibiting Porphyromonas gingivalis

  • FP

    Frontiers Production Office

  • Frontiers Media SA, Lausanne, Switzerland

In the published article, there was an error in Figures 2E, 2H, 4E as published. The micrometers on the scale were erroneously written as nanometers. The corrected Figures 2E, 2H, 4E, and their respective captions, appear below.

Figure 2

Figure 4

The original version of this article has been updated.

Summary

Keywords

periodontitis, mesalazine, Porphyromonas gingivalis, plaque biofilm, inflammatory bowel disease

Citation

Frontiers Production Office (2025) Correction: Mesalazine: a novel therapeutic agent for periodontitis via regulation of periodontal microbiota and inhibiting Porphyromonas gingivalis. Front. Microbiol. 16:1638611. doi: 10.3389/fmicb.2025.1638611

Received

31 May 2025

Accepted

27 June 2025

Published

11 July 2025

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

16 - 2025

Updates

Copyright

*Correspondence: Frontiers Production Office

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics